Working… Menu

Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02188537
Recruitment Status : Completed
First Posted : July 11, 2014
Last Update Posted : June 26, 2019
Information provided by (Responsible Party):
Swiss Group for Clinical Cancer Research